The tweet was deleted by the author.
But we saved everything 🙂.
Cognizant is expanding its partnership with Novartis through a new five-year, AI-enabled integrated IT operations engagement.
The engagement will bring together applications, infrastructure, security, digital workplace and platform services into a unified operating model. Cognizant and Novartis have partnered for over 20 years.
View post on X Loading...
CTSH is currently trading at $46.54, sitting above its MA-20 ($42.69) but just below the MA-50 ($47.15) and well under the long-term MA-200 ($64.43), signaling bullish momentum in the short term but persistent medium- and long-term bearish pressure. The Ichimoku Kijun on D1 is at $44.03, which serves as immediate support, while near-term resistance lies at MA-50 ($47.15) and key resistance at MA-100 ($53.05). Near-term support is clustered around the Ichimoku Kijun ($44.03), with key support at MA-20 ($42.69).
Momentum indicators on D1 are mixed: MACD signals a strong sell and ADX also leans bearish, yet RSI remains in buy territory at 53.17. Both Stoch RSI and CCI are strongly overbought, and BBP indicates dominant buyer pressure with a reading of 1.67. The Awesome Oscillator is neutral and does not confirm the bullish push. In today's session, CTSH has gained 2.40%, climbing $1.09 as buyers push the price toward weekly resistance. CTSH is trading at $46.54, up from $45.45 a week ago, reflecting a 2.29% increase. The price is at the very top of the weekly range, and weekly volatility stands at 7.93%. The current tone is a recovery from the weekly low, but sharp intraday gains and overbought readings caution that further upside is likely to face resistance.
For the next week, the expected trading range is $44.00 to $48.00, anchoring support and resistance within 10% of the current price given typical volatility. This range remains well above the 52-week low ($37.08), but far below the 52-week high ($87.03), underscoring the stock's longer-term weakness. Based on the W1 indicators (all in sell mode), there is a very low probability (less than 20%) of further upside, making a decline the more likely scenario. The baseline expectation is for CTSH to consolidate between $44.00 and $48.00. In a bullish case, a break above $48.00 could look to test the MA-100 ($53.05), while a bearish move below $44.00 might trigger a retest of the $42.69 support area.
Previously it was reported that Cognizant remained under sustained bearish pressure, with analysts expecting continued consolidation near multi-year lows. This article adds a new dimension by considering recent developments, and investors should monitor for any signs of momentum reversal that could signal a shift from the prevailing downtrend.